81_FR_69734 81 FR 69540 - Center for Scientific Review: Notice of Closed Meetings

81 FR 69540 - Center for Scientific Review: Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 194 (October 6, 2016)

Page Range69540-69541
FR Document2016-24126

Federal Register, Volume 81 Issue 194 (Thursday, October 6, 2016) 
[Federal Register Volume 81, Number 194 (Thursday, October 6, 2016)]
[Notices]
[Pages 69540-69541]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-24126]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review: Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Diseases and Pathophysiology of the Visual 
System Study Section.
    Date: October 27-28, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites DC Convention Center, 900 10th Street NW., 
Washington, DC 20001.
    Contact Person: Nataliya Gordiyenko, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD 
20892, 301.435.1265, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Mucosal Inflammation, Allergy and Asthma.
    Date: October 28, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person:
    Deborah Hodge, Ph.D., Scientific Review Officer, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4207 MSC 7812, Bethesda, MD 20892, (301) 435-1238, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Conferences and Meetings: Office of Research Infrastructure 
Programs (ORIP).
    Date: October 31, 2016.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Cathleen L. Cooper, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2130, MSC 7720, Bethesda, MD 
20892, 301-443-4512, [email protected].

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Infectious Diseases, Reproductive Health, 
Asthma and Pulmonary Conditions, Study Section.
    Date: November 2-3, 2016.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 
20036.
    Contact Person: Lisa Steele, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 257-
2638, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Review of Neuroscience AREA Grant Applications.
    Date: November 3-4, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island 
Avenue NW., Washington, DC 20036.
    Contact Person: Richard D. Crosland, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 
20892, 301-435-1220, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Drug Discovery and Mechanisms of Antimicrobial 
Resistance.
    Date: November 3-4, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton McLean Tysons Corner, 7920 Jones Branch Drive, 
McLean, VA 22102.
    Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
1146, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Clinical Neuroscience and Disease.
    Date: November 3, 2016.
    Time: 11:00 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Bruce Reed, Ph.D., Director Division, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4160, MSC 7806, Bethesda, MD 20892, 301-594-9159, 
[email protected].


[[Page 69541]]


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Drug Discovery and Mechanisms of Antimicrobial Resistance.
    Date: November 3, 2016.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton McLean Tysons Corner, 7920 Jones Branch Drive, 
McLean, VA 22102.
    Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3114, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 30, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-24126 Filed 10-5-16; 8:45 am]
 BILLING CODE 4140-01-P

69540 Federal Register / Vol. 81, No. 194 / Thursday, October 6, 2016 / Notices to submit written comments via mail, Dated: September 29, 2016. Agenda: To review and evaluate grant fax, and email (see contact information Carolyn Baum, applications. Place: National Institutes of Health, 6701 above). Comments received in response Program Analyst, Office of Federal Advisory Rockledge Drive, Bethesda, MD 20892, to this notice will be reviewed and Committee Policy. (Telephone Conference Call). considered by the appropriate topic area [FR Doc. 2016–24125 Filed 10–5–16; 8:45 am] Contact Person: Cathleen L. Cooper, Ph.D., workgroup, Federal Interagency BILLING CODE 4140–01–P Scientific Review Officer, Center for Workgroup on Healthy People 2020, and Scientific Review, National Institutes of other Healthy People 2020 stakeholders. Health, 6701 Rockledge Drive, Room 2130, DEPARTMENT OF HEALTH AND MSC 7720, Bethesda, MD 20892, 301–443– Dated: October 3, 2016. HUMAN SERVICES 4512, cooperc@csr.nih.gov. Don Wright, Name of Committee: Population Sciences Deputy Assistant Secretary for Health National Institutes of Health and Epidemiology Integrated Review Group; Infectious Diseases, Reproductive Health, (Disease Prevention and Health Promotion). Center for Scientific Review: Notice of Asthma and Pulmonary Conditions, Study [FR Doc. 2016–24250 Filed 10–5–16; 8:45 am] Section. Closed Meetings BILLING CODE 4150–32–P Date: November 2–3, 2016. Pursuant to section 10(d) of the Time: 8:30 a.m. to 6:00 p.m. Federal Advisory Committee Act, as Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND amended (5 U.S.C. App.), notice is applications. hereby given of the following meetings. Place: St. Gregory Hotel, 2033 M Street HUMAN SERVICES NW., Washington, DC 20036. The meetings will be closed to the Contact Person: Lisa Steele, Ph.D., National Institutes of Health public in accordance with the Scientific Review Officer, Center for provisions set forth in sections Scientific Review, National Institutes of Center for Scientific Review; Notice of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Health, 6701 Rockledge Drive, Room 3139, Closed Meeting as amended. The grant applications and MSC 7770, Bethesda, MD 20892, (301) 257– the discussions could disclose 2638, steeleln@csr.nih.gov. Pursuant to section 10(d) of the confidential trade secrets or commercial Name of Committee: Center for Scientific Federal Advisory Committee Act, as property such as patentable material, Review Special Emphasis Panel; Review of amended (5 U.S.C. App.), notice is and personal information concerning Neuroscience AREA Grant Applications. individuals associated with the grant Date: November 3–4, 2016. hereby given of the following meeting. Time: 8:00 a.m. to 6:00 p.m. The meeting will be closed to the applications, the disclosure of which Agenda: To review and evaluate grant public in accordance with the would constitute a clearly unwarranted applications. invasion of personal privacy. Place: Beacon Hotel and Corporate provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: Brain Disorders and Quarters, 1615 Rhode Island Avenue NW., Clinical Neuroscience Integrated Review Washington, DC 20036. as amended. The grant applications and Contact Person: Richard D. Crosland, Group; Diseases and Pathophysiology of the the discussions could disclose Visual System Study Section. Ph.D., Scientific Review Officer, Center for confidential trade secrets or commercial Date: October 27–28, 2016. Scientific Review, National Institutes of property such as patentable material, Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 4190, and personal information concerning Agenda: To review and evaluate grant MSC 7850, Bethesda, MD 20892, 301–435– applications. 1220, crosland@nih.gov. individuals associated with the grant Place: Embassy Suites DC Convention Name of Committee: Center for Scientific applications, the disclosure of which Center, 900 10th Street NW., Washington, DC Review Special Emphasis Panel; Topics in would constitute a clearly unwarranted 20001. Drug Discovery and Mechanisms of invasion of personal privacy. Contact Person: Nataliya Gordiyenko, Antimicrobial Resistance. Ph.D., Scientific Review Officer, Center for Date: November 3–4, 2016. Name of Committee: Center for Scientific Scientific Review, National Institutes of Time: 8:00 a.m. to 5:00 p.m. Review Special Emphasis Panel; P01 Review: Health, 6701 Rockledge Drive, Room 5202, Agenda: To review and evaluate grant Heroin Addiction. MSC 7846, Bethesda, MD 20892, applications. Date: October 14, 2016. 301.435.1265, gordiyenkon@csr.nih.gov. Place: Hilton McLean Tysons Corner, 7920 Time: 1:00 p.m. to 5:00 p.m. Name of Committee: Center for Scientific Jones Branch Drive, McLean, VA 22102. Agenda: To review and evaluate grant Review Special Emphasis Panel; Mucosal Contact Person: Guangyong Ji, Ph.D., applications. Inflammation, Allergy and Asthma. Scientific Review Officer, Center for Place: Washington Plaza Hotel, 10 Thomas Date: October 28, 2016. Scientific Review, National Institutes of Circle NW., Washington, DC 20005. Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 3211, Contact Person: Jana Drgonova, Ph.D., Agenda: To review and evaluate grant MSC 7808, Bethesda, MD 20892, 301–435– Scientific Review Officer, Center for applications. 1146, jig@csr.nih.gov. Scientific Review, National Institutes of Place: Embassy Suites at the Chevy Chase Name of Committee: Center for Scientific Pavilion, 4300 Military Road NW., Review Special Emphasis Panel; Member Health, 6701 Rockledge Drive, Room 5213, Washington, DC 20015. Conflict: Clinical Neuroscience and Disease. Bethesda, MD 20892, jdrgonova@ Contact Person: Date: November 3, 2016. mail.nih.gov. Deborah Hodge, Ph.D., Scientific Review Time: 11:00 a.m. to 2:30 p.m. This notice is being published less than 15 Officer, Center for Scientific Review, Agenda: To review and evaluate grant days prior to the meeting due to the timing National Institutes of Health, 6701 Rockledge applications. limitations imposed by the review and Drive, Room 4207 MSC 7812, Bethesda, MD Place: National Institutes of Health, 6701 sradovich on DSK3GMQ082PROD with NOTICES funding cycle. 20892, (301) 435–1238, hodged@ Rockledge Drive, Bethesda, MD 20892, mail.nih.gov. (Virtual Meeting). (Catalogue of Federal Domestic Assistance Name of Committee: Center for Scientific Contact Person: Bruce Reed, Ph.D., Program Nos. 93.306, Comparative Medicine; Review Special Emphasis Panel; Conferences Director Division, Center for Scientific 93.333, Clinical Research, 93.306, 93.333, and Meetings: Office of Research Review, National Institutes of Health, 6701 93.337, 93.393–93.396, 93.837–93.844, Infrastructure Programs (ORIP). Rockledge Drive, Room 4160, MSC 7806, 93.846–93.878, 93.892, 93.893, National Date: October 31, 2016. Bethesda, MD 20892, 301–594–9159, reedbr@ Institutes of Health, HHS) Time: 1:00 p.m. to 3:00 p.m. mail.nih.gov. VerDate Sep<11>2014 18:46 Oct 05, 2016 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1

Federal Register / Vol. 81, No. 194 / Thursday, October 6, 2016 / Notices 69541 Name of Committee: Center for Scientific Rockville, MD 20892, (240) 669–5060, DEPARTMENT OF HEALTH AND Review Special Emphasis Panel; Drug james.snyder@nih.gov. HUMAN SERVICES Discovery and Mechanisms of Antimicrobial (Catalogue of Federal Domestic Assistance Resistance. Program Nos. 93.855, Allergy, Immunology, National Institutes of Health Date: November 3, 2016. and Transplantation Research; 93.856, Time: 1:00 p.m. to 3:00 p.m. Microbiology and Infectious Diseases Government-Owned Inventions; Agenda: To review and evaluate grant Research, National Institutes of Health, HHS) Availability for Licensing applications. Place: Hilton McLean Tysons Corner, 7920 Dated: September 30, 2016. AGENCY: National Institutes of Health, Jones Branch Drive, McLean, VA 22102. Natasha M. Copeland, HHS. Contact Person: John C. Pugh, Ph.D., Program Analyst, Office of Federal Advisory ACTION: Notice. Scientific Review Officer, Center for Committee Policy. Scientific Review, National Institutes of SUMMARY: The invention listed below is [FR Doc. 2016–24129 Filed 10–5–16; 8:45 am] Health, 6701 Rockledge Drive, Room 3114, owned by an agency of the U.S. MSC 7808, Bethesda, MD 20892, (301) 435– BILLING CODE 4140–01–P 2398, pughjohn@csr.nih.gov. Government and is available for licensing. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; DEPARTMENT OF HEALTH AND FOR FURTHER INFORMATION CONTACT: 93.333, Clinical Research, 93.306, 93.333, HUMAN SERVICES Licensing information and copies of the 93.337, 93.393–93.396, 93.837–93.844, U.S. patent application listed below 93.846–93.878, 93.892, 93.893, National National Institutes of Health may be obtained by communicating Institutes of Health, HHS) with the indicated licensing contact at National Institute of Allergy and the Technology Transfer and Dated: September 30, 2016. Infectious Diseases: Notice of Closed Intellectual Property Office, National Natasha M. Copeland, Meeting Program Analyst, Office of Federal Advisory Institute of Allergy and Infectious Committee Policy. Diseases, 5601 Fishers Lane, Rockville, Pursuant to section 10(d) of the [FR Doc. 2016–24126 Filed 10–5–16; 8:45 am] MD 20852; tel. 301–496–2644. A signed Federal Advisory Committee Act, as Confidential Disclosure Agreement will BILLING CODE 4140–01–P amended (5 U.S.C. App.), notice is be required to receive copies of hereby given of the following meeting. unpublished patent applications. DEPARTMENT OF HEALTH AND The meeting will be closed to the SUPPLEMENTARY INFORMATION: The HUMAN SERVICES public in accordance with the invention listed below is owned by an provisions set forth in sections agency of the U.S. Government and is National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., available for licensing in the U.S. in as amended. The grant applications and accordance with 35 U.S.C. 209 and 37 National Institute of Allergy and the discussions could disclose CFR part 404 to achieve expeditious Infectious Diseases: Notice of Closed confidential trade secrets or commercial commercialization of results of Meeting property such as patentable material, federally-funded research and and personal information concerning development. Foreign patent Pursuant to section 10(d) of the individuals associated with the grant applications are filed on selected Federal Advisory Committee Act, as applications, the disclosure of which inventions to extend market coverage amended (5 U.S.C. App.), notice is would constitute a clearly unwarranted for companies and may also be available hereby given of the following meeting. invasion of personal privacy. for licensing. Technology description The meeting will be closed to the public in accordance with the Name of Committee: National Institute of follows. provisions set forth in sections Allergy and Infectious Diseases Special Use of Roseomonas species to treat 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Emphasis Panel Consortium for Food Allergy eczematous (atopic dermatitis) skin Research: Clinical Research Units (UM1). disease Description of Technology: as amended. The grant applications and Date: November 16–18, 2016. Atopic dermatitis, also known as the discussions could disclose Time: 7:30 p.m. to 6:00 p.m. confidential trade secrets or commercial eczema, is a chronic itchy skin disease Agenda: To review and evaluate grant that affects over 20% of infants and property such as patentable material, applications. and personal information concerning young children in industrialized nations Place: The William F. Bolger Center, 9600 individuals associated with the grant Newbridge Drive, Potomac, MD 20854. and may persist into adulthood for up applications, the disclosure of which Contact Person: Louis A. Rosenthal, Ph.D., to 50% of these cases, making it one of would constitute a clearly unwarranted Scientific Review Officer Scientific Review the most common skin diseases in the invasion of personal privacy. Program, Division of Extramural Activities, US and other developed countries. Rm 3G42B National Institutes of Health/ Scientists at NIAID have developed a Name of Committee: National Institute of NIAID, 5601 Fishers Lane, MSC–79823 method of treating or preventing atopic Allergy and Infectious Diseases Special Bethesda, MD 20892–9823, (240) 669–5070, dermatitis via the topical application of Emphasis Panel; Lasker Clinical Research rosenthalla@niaid.nih.gov. selected probiotic strains of gram- Scholars Program (Si2/R00). Date: November 1, 2016. (Catalogue of Federal Domestic Assistance negative Roseomonas mucosa bacteria. Time: 2:00 p.m. to 5:00 p.m. Program Nos. 93.855, Allergy, Immunology, This approach avoids the exhausting Agenda: To review and evaluate grant and Transplantation Research; 93.856, treatment demands of standard applications. Microbiology and Infectious Diseases therapies and has been shown to be sradovich on DSK3GMQ082PROD with NOTICES Place: National Institutes of Health, 5601 Research, National Institutes of Health, HHS) beneficial in a preclinical mouse model Fishers Lane, Rockville, MD 20892, Dated: September 30, 2016. of atopic dermatitis. (Telephone Conference Call). Natasha M. Copeland, Potential Commercial Applications: Contact Person: James T. Snyder, Ph.D., • Treatment of eczema Program Analyst, Office of Federal Advisory Scientific Review Officer, Scientific Review Committee Policy. Competitive Advantages: Program, Division of Extramural Activities/ Room 3G31B National Institutes of Health, [FR Doc. 2016–24130 Filed 10–5–16; 8:45 am] • May be formulated as a cream or NIAID, 5601 Fishers Lane MSC 9823, BILLING CODE 4140–01–P ointment VerDate Sep<11>2014 18:46 Oct 05, 2016 Jkt 241001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1


Document Created: 2016-10-06 02:38:22
Document Modified: 2016-10-06 02:38:22
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 27-28, 2016.
FR Citation81 FR 69540 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR